|
1
|
Wu S, Wang X, Xing W, Li F, Liang M, Li K,
He Y and Wang J: An update on animal models of liver fibrosis.
Front Med (Lausanne). 10(1160053)2023.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Faccioli LAP, Dias ML, Paranhos BA and Dos
Santos Goldenberg RC: Liver cirrhosis: An overview of experimental
models in rodents. Life Sci. 301(120615)2022.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Zeng Z, Lei Y, Yang C, Wu X, Zhang L, Yang
Z, Chen L, Wang X, Belguise K, Li Y and Yi B: The therapeutic
effects of baicalein on the hepatopulmonary syndrome in the rat
model of chronic common bile duct ligation. J Clin Transl Hepatol.
12:496–504. 2024.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Perlman RL: Mouse models of human disease:
An evolutionary perspective. Evol Med Public Health. 2016:170–176.
2016.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Lee YS and Seki E: In vivo and in vitro
models to study liver fibrosis: Mechanisms and limitations. Cell
Mol Gastroenterol Hepatol. 16:355–367. 2023.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Mariotti V, Cadamuro M, Spirli C, Fiorotto
R, Strazzabosco M and Fabris L: Animal models of cholestasis: An
update on inflammatory cholangiopathies. Biochim Biophys Acta Mol
Basis Dis. 1865:954–964. 2019.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Kolaric TO, Kuna L, Covic M, Roguljic H,
Matic A, Sikora R, Hefer M, Petrovic A, Mihaljevic V, Smolic R, et
al: Preclinical models and promising pharmacotherapeutic strategies
in liver fibrosis: An update. Curr Issues Mol Biol. 45:4246–4260.
2023.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Marques TG, Chaib E, da Fonseca JH,
Lourenço AC, Silva FD, Ribeiro MA Jr, Galvão FH and D'Albuquerque
LA: Review of experimental models for inducing hepatic cirrhosis by
bile duct ligation and carbon tetrachloride injection. Acta Cir
Bras. 27:589–594. 2012.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Smith GP: Animal models of cutaneous and
hepatic fibrosis. Prog Mol Biol Transl Sci. 105:371–409.
2012.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Starkel P and Leclercq IA: Animal models
for the study of hepatic fibrosis. Best Pract Res Clin
Gastroenterol. 25:319–333. 2011.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Bao YL, Wang L, Pan HT, Zhang TR, Chen YH,
Xu SJ, Mao XL and Li SW: Animal and organoid models of liver
fibrosis. Front Physiol. 12(666138)2021.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Feng S, Tong H, Gao JH, Tang SH, Yang WJ,
Wang GM, Zhou HY and Wen SL: Anti-inflammation treatment for
protection of hepatocytes and amelioration of hepatic fibrosis in
rats. Exp Ther Med. 22(1213)2021.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Krishna M: Histological grading and
staging of chronic hepatitis. Clin Liver Dis (Hoboken). 17:222–226.
2021.PubMed/NCBI View
Article : Google Scholar
|
|
14
|
Radosavljevic T, Vukicevic D, Djuretić J,
Gopcevic K, Labudovic Borovic M, Stankovic S, Samardzic J,
Radosavljevic M, Vucevic D and Jakovljevic V: The role of
macrophage inhibitory factor in TAA-induced liver fibrosis in mice:
Modulatory effects of betaine. Biomedicines.
12(1337)2024.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Wen SL, Feng S, Tang SH, Gao JH, Zhang LH,
Tong H, Yan ZP and Fang DZ: Collapsed reticular network and its
possible mechanism during the initiation and/or progression of
hepatic fibrosis. Sci Rep. 6(35426)2016.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Kim JY, Jun JH, Park SY, Yang SW, Bae SH
and Kim GJ: Dynamic regulation of miRNA expression by functionally
enhanced placental mesenchymal stem cells promoteshepatic
regeneration in a rat model with bile duct ligation. Int J Mol Sci.
20(5299)2019.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Yang YT, Ji MR, Lin ZJ, Li P, Wu RZ, Liu
XD and Liu L: Bile duct ligation impairs visual acuity in rats by
ammonia- and bilirubin-induced retinal degeneration. Acta Pharmacol
Sin. 46:380–392. 2025.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Najibi A, Rezaei H, Manthari RK, Niknahad
H, Jamshidzadeh A, Farshad O, Yan F, Ma Y, Xu D, Tang Z, et al:
Cellular and mitochondrial taurine depletion in bile duct ligated
rats: A justification for taurine supplementation in
cholestasis/cirrhosis. Clin Exp Hepatol. 8:195–210. 2022.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Patel C, Shahgond L, Acharya S, Boddu SH
and Ranch K: Protective effect of probiotics and ascorbic acid on
bile duct ligation-induced chronic hepatic encephalopathy in rats.
Res Pharm Sci. 17:445–456. 2022.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Wan X, Fang Y, Qin M, Zheng Q, Yang Q,
Peng M, Hao M, Wang K, Zhao R, Shi Y, et al: Protective effect of
MP-40 mitigates BDL-induced hepatic fibrosis by inhibiting the
NLRP3-mediated pyroptosis. Front Pharmacol.
15(1479503)2024.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Zhang N, Niu W, Niu W, Li Y, Guo S, Li Y,
He W and He H: Isovalerylspiramycin I alleviates liver injury and
liver fibrosis by targeting the nucleotide-binding protein 2
(NUBP2)-vascular non-inflammatory molecule-1 (VNN1) pathway. J
Pharm Anal. 15(101048)2025.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Pun CK, Huang HC, Chang CC, Hsu SJ, Chuang
CL, Huang YH, Hou MC and Lee FY: Low-dose alcohol exacerbates
hyperdynamic circulation and shunting in non-alcoholic cirrhotic
rats. Biosci Rep. 44(BSR20240354)2024.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Semenovich DS, Zorova LD, Abramicheva PA,
Andrianova NV, Elchaninov AV, Petrukhina AS, Pevzner IB, Manskikh
VN, Zorov DB and Plotnikov EY: Impact of intermittent fasting and
dietary restriction on redox state, energetic metabolism, and liver
injury in common bile duct ligation model. Antioxidants (Basel).
13(835)2024.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Hajiasgharzadeh K, Shahabi P, Karimi-Sales
E and Alipour MR: Nicotine promotes development of bile duct
ligation-induced liver fibrosis by increasing expression of
nicotinic acetylcholine receptors in rats. Clin Exp Hepatol.
10:62–71. 2024.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Roeb E: Matrix metalloproteinases and
liver fibrosis (translational aspects). Matrix Biol. 68-69:463–473.
2018.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Suckow MA, Wilson RP, Hankenson FC and
Foley PL: The laboratory rat. Elsevier, 2019.
|
|
27
|
Verhoven B, Zeng W, Chlebeck P, Matkowskyj
K, Jennings H, Poore S and Al-Adra D: Heterotopic auxiliary whole
liver rat transplant model utilizing a hepaticoureterostomy for
allograft rejection studies. J Vis Exp: 10.3791/66516, 2024.
|
|
28
|
Zou Y, Yue P, Cao H, Wu L, Xu L, Liu Z, Wu
S and Ye Q: A novel ameliorated rat model of reversible obstructive
jaundice. J Zhejiang Univ Sci B. 24:345–351. 2023.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Du Y, Chen H, Xuan Z, Song W, Hong L, Guo
D, Li H, Tuo B, Zheng S and Song P: Bile deficiency induces changes
in intestinal glucose absorption in mice. Surgery. 160:1496–1507.
2016.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Lyu SC, Wang J, Xu WL, Wang HX, Pan F,
Jiang T, He Q and Lang R: Therapeutic effect of combining
anisodamine with neostigmine on local scar formation following
Roux-en-Y choledochojejunostomy in a novel rat model. Front
Pharmacol. 12(700050)2021.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Huang X, Li CH, Zhang AQ, Kong Z, Gu WQ
and Dong JH: A simple rat model of in situ reversible obstructive
jaundice in situ reversible obstructive jaundice model. Ann Surg
Treat Res. 92:389–395. 2017.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Luo WW, Zhou XL, Wang QQ, Shao YJ, Li ZM,
Zhao DK and Yu SP: The application of Compont gel in chronic
obstructive jaundice rats model. Acta Cir Bras.
34(e201900504)2019.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Apostu RC, Ciuce CC, Făgărăşan V, Scurtu
RR and Ciuce C: Hepatoportoenterostomy in selective obstructive
cholestasis-an new experimental model in the rat. Chirurgia
(Bucur). 115:252–260. 2020.PubMed/NCBI View Article : Google Scholar
|
